Impact of anti-T-lymphocyte globulin dosing on graft versus host disease in matched sibling peripheral blood stem cell transplantation [0.03%]
抗T淋巴细胞免疫球蛋白的剂量对同胞全相合外周血造血干细胞移植后移植物抗宿主病的影响
Radwan Massoud,Evgeny Klyuchnikov,Silke Heidenreich et al.
Radwan Massoud et al.
Anti-T-lymphocyte globulin (ATLG) is commonly administered to reduce graft-versus-host disease (GVHD) in allogeneic stem cell transplantation (allo-SCT). However, the optimal ATLG dose in matched-sibling-donor (MSD) peripheral blood stem-ce...
Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults [0.03%]
布ем洛苏滴治疗儿童和青年人慢性移植物抗宿主病的现实世界经验
Azada Ibrahimova,Alan Bidgoli,Arfa Ashraf et al.
Azada Ibrahimova et al.
Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with cutaneous T-cell lymphoma [0.03%]
intermediate-dose TBI/fludarabine预处理方案用于皮肤T细胞淋巴瘤患者的allo-HSCT
Isabelle Krämer,Laila König,Arne Brecht et al.
Isabelle Krämer et al.
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland [0.03%]
德国和瑞士复发/难治性套细胞淋巴瘤患者接受倍林妥莫双抗治疗的常规临床结果
Linda Simon,Vladan Vucinic,Kai Rejeski et al.
Linda Simon et al.
Defibrotide for prophylaxis of sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD) in pediatric high-risk patients: consensus guidelines from the European Society for Blood and Marrow Transplantation (EBMT) [0.03%]
欧洲血液和骨髓移植协会(EBMT)关于在高危儿科患者中预防肝小静脉闭塞病/肝窦阻塞综合征(SOS/VOD)的防治共识：defibrotide药物指南
Selim Corbacioglu,Rajinder Bajwa,Ali Bülent Antmen et al.
Selim Corbacioglu et al.
SOS/VOD is a life-threatening complication of hematopoietic stem cell transplantation, especially in children, with incidences reaching up to 15-20%. Despite efforts, SOS/VOD remains unpredictable with significant morbidity and mortality. H...
Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study [0.03%]
亚洲成人HSCT受者TA-TMA风险分层及新型预后生物标志物的多中心真实世界研究验证
Yibo Wu,Xiaolin Yuan,Lieguang Chen et al.
Yibo Wu et al.
Background: Transplantation-associated thrombotic microangiopathy (TA-TMA) confers high mortality after allogeneic hematopoietic stem cell transplantation (HSCT). While characteristics are established in pediatric populat...
Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma? [0.03%]
改良的淋巴耗竭预处理方案能否改善tisagenlecleucel治疗大B细胞淋巴瘤高危患者的结果？
Marta Canelo-Vilaseca,Mohamad Sabbah,Caterina Cristinelli et al.
Marta Canelo-Vilaseca et al.
Correction: Real-world medical expenses of hematopoietic stem cell transplantation in Japan: a nationwide database study [0.03%]
纠正：日本造血干细胞移植的现实世界医疗费用：一项全国数据库研究
Mizuki Watanabe,Shosuke Ohtera,Junya Kanda et al.
Mizuki Watanabe et al.
Published Erratum
Bone marrow transplantation. 2026 Jan 7. DOI:10.1038/s41409-025-02781-1 2026
Human cytomegalovirus-specific T-cell responses and immune-guided strategies as predictors of clinically significant infection in hematopoietic stem cell transplant recipients after letermovir prophylaxis [0.03%]
造血干细胞移植受者在接受雷特莫韦预防后，人类巨细胞病毒特异性T细胞反应和免疫指导策略作为临床显著感染预测因子的影响
Dalila Mele,Michele Malagola,Federica Zavaglio et al.
Dalila Mele et al.
Outcomes of patients with HTLV-1 adult T-cell leukemia/lymphoma (ATLL) after allogeneic SCT: results of the EBMT LWP [0.03%]
同种异体干细胞移植治疗人类T细胞白血病病毒Ⅰ型成人T细胞白血病/淋巴瘤患者的预后：EBMT工作组结果分析
Patricia López-Pereira,Ali Bazarbachi,Ambroise Marçais et al.
Patricia López-Pereira et al.
Adult T-cell leukemia/lymphoma (ATLL) is a rare HTLV-1-associated malignancy with a dismal prognosis due to intrinsic chemoresistance and immunosuppression. This retrospective EBMT registry analysis evaluated outcomes of allogeneic stem cel...